Roxo, Maria InêsPepe, BrunoBirne, Rita2024-12-182024-12-1820230101-2800PURE: 104468042PURE UUID: 9ab74d22-724b-4370-9834-c811f088f9d2Scopus: 85174859118PubMed: 37071822http://hdl.handle.net/10362/176493Funding Information: R. Birne reports the following: employed by Diaverum; research funding from Gilead, Bayer, and Boehringer; member in advisory board of Bayer and Boehringer; and member of the speakers bureau of AstraZeneca, Bayer, Boehringer, MSD and Bial. M. Roxo reports the following: employed by Fresenius Medical Care.2271764engNephrologyjournal article10.1590/2175-8239-JBN-2023-0011enhttps://www.scopus.com/pages/publications/85174859118